Syndecan-1 and KRAS Gene Expression Signature Associates With Patient Survival in Pancreatic Cancer
Conclusions
SDC1 interplays with KRAS, and targeting both KRAS and SDC1 in combination may be more beneficial to pancreatic cancer patients.
Source: Pancreas - Category: Gastroenterology Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Gastroenterology | Genetics | Pancreas | Pancreatic Cancer | Study